• Home
• Media centre
• Pandemic flu
• H1N1 Press releases

H1N1 Press releases

2011

21 July 2011
GlaxoSmithKline European regulatory update on Pandemrix™

18 April 2011
GSK welcomes key agreement to support global preparedness against pandemic influenza

15 April 2011
GSK European regulatory update on Pandemrix™

18 February 2011
GSK European regulatory update on Pandemrix™ (PDF)

1 February 2011
Update on Pandemrix™ and interim Finnish report on narcolepsy

2010

23 September 2010
GSK EU regulatory update on Pandemrix™

2 September 2010
Reports of narcolepsy in Europe following vaccination with Pandemrix™

26 March 2010
GlaxoSmithKline update: Government orders for pandemic H1N1 vaccine

15 January 2010
GlaxoSmithKline update: Government orders for pandemic H1N1 vaccine

12 January 2010
GlaxoSmithKline update: Government orders for pandemic H1N1 vaccine

2009

4 December 2009
GSK Statement: H1N1 pandemic update on paediatric data for Pandemrix (PDF 96Kb)

1 December 2009
GSK Update: GSK’s Arepanrix™ H1N1 pandemic vaccine prequalified by the World Health Organization

24 November 2009
GSK Statement: Voluntary hold of Arepanrix (adjuvanted H1N1 pandemic vaccine) lot number A80CA007A in Canada (PDF 94Kb)

23 November 2009
Pandemic 2009 Influenza Update: Pandemrix™ data in children and adolescents from 3 to 17 years of age

10 November 2009
Pandemic 2009 Influenza Update: US FDA approves GSK’s pandemic H1N1 vaccine

10 November 2009
GSK signs agreement with the WHO to donate 50 million doses of pandemic H1N1 vaccine for distribution to developing countries

9 November 2009
Pandemic 2009 Influenza Update: Pandemrix™ data on co-administration with annual seasonal influenza vaccine (Fluarix®)

27 October 2009
Pandemic 2009 Influenza Update: Pandemrix™ data in an elderly population

23 October 2009
Pandemic (H1N1) 2009 Influenza Update: Experience of GSK’s H1N1 adjuvanted vaccine, Pandemrix™, and preliminary paediatric results

16 October 2009
Pandemic (H1N1) 2009 Influenza Update: Results from second clinical trial of GSK’s H1N1 adjuvanted vaccine confirm immune response and tolerability

6 October 2009
GlaxoSmithKline update: Government orders for pandemic (H1N1) 2009 vaccine

30 September 2009
Pandemic (H1N1) 2009 influenza update: GSK’s H1N1 Pandemrix vaccine receives European Commission approval

25 September 2009
Pandemic (H1N1) 2009 Influenza Update: GSK’s H1N1 ‘Pandemrix’ vaccine receives positive opinion from European Regulators

14 September 2009
Pandemic (H1N1) 2009 Influenza Update: Initial results from first clinical trial of GSK’s H1N1 adjuvanted vaccine

14 August 2009
Pandemic (H1N1) 2009 influenza update

4 August 2009
GlaxoSmithKline update: Government orders for pandemic (H1N1) 2009 vaccine

22 July 2009
Pandemic (H1N1) 2009 Influenza Update

12 June 2009
GlaxoSmithKline update: influenza A (H1N1)

22 May 2009
US Department of Health and Human Services (HHS) purchases GSK’s A (H1N1) influenza antigen and proprietary adjuvant system

15 May 2009
GlaxoSmithKline update: A (H1N1) influenza vaccine development

1 May 2009
GlaxoSmithKline update: influenza A (H1N1)